Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lessened its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 13.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 272,471 shares of the health services provider's stock after selling 42,020 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.16% of Teladoc Health worth $2,114,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in TDOC. Golden State Wealth Management LLC lifted its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares during the period. Sterling Capital Management LLC increased its holdings in shares of Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after purchasing an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $60,000. Generali Investments Management Co LLC purchased a new position in Teladoc Health in the fourth quarter worth approximately $64,000. Finally, PNC Financial Services Group Inc. grew its position in Teladoc Health by 22.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock worth $73,000 after acquiring an additional 1,439 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insiders Place Their Bets

In other Teladoc Health news, insider Fernando M. Rodrigues sold 4,174 shares of the firm's stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the sale, the insider directly owned 17,645 shares in the company, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock valued at $128,189 over the last quarter. Insiders own 0.58% of the company's stock.

Teladoc Health Stock Up 5.5%

NYSE:TDOC traded up $0.44 during mid-day trading on Tuesday, reaching $8.51. The stock had a trading volume of 7,195,871 shares, compared to its average volume of 6,921,554. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.68 and a quick ratio of 1.64. The stock's 50 day simple moving average is $7.35 and its two-hundred day simple moving average is $8.68. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of -1.44 and a beta of 1.84.

Analyst Ratings Changes

A number of research analysts recently issued reports on TDOC shares. The Goldman Sachs Group decreased their target price on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Canaccord Genuity Group dropped their price target on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Evercore ISI lowered their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a report on Thursday, May 1st. Wells Fargo & Company reduced their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 8th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Teladoc Health currently has an average rating of "Hold" and a consensus target price of $9.60.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.